glp-1 and eye disease Danny D. | 👁️ Important safety update from the *BMJ*: Emerging evidence regulatory reviews are prompting new warnings about a potential link GLP-1 Drugs and Ocular Disease:

Multiple peptidereceptor systems regulate glucose utilization, lipid handling, mitochondrial efficiency, and substrate partitioning independently of insulin secretion

doi: 10.3390/ph17091181 298 RoytrakulSCharoenlappanitSKittisenachaiSSiangproNSichaemJChuakrutSet al

Among these are insulin resistance, elevated levels of low-density lipoprotein (LDL) cholesterol and hyperuricemia, which is an excessive buildup of uric acid

Aphid genome expression reveals hostsymbiont cooperation in the production of amino acids

Nausea is the single most common complaint, affecting a significant percentage of users especially during dose escalation